HALEON PLC (HLN)

Currency in GBP
355.80
-9.60(-2.63%)
Closed·
HLN Scorecard
Full Analysis
Management has been aggressively buying back shares
HLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
355.80365.40
52 wk Range
346.10419.40
Key Statistics
Bid/Ask
349.80 / 395.00
Prev. Close
365.4
Open
365.4
Day's Range
355.8-365.4
52 wk Range
346.1-419.4
Volume
16.61M
Average Volume (3m)
23.65M
1-Year Change
-0.65%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HLN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
415.88
Upside
+16.89%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

HALEON PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

HALEON PLC Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Employees
24561

Compare HLN to Peers and Sector

Metrics to compare
HLN
Peers
Sector
Relationship
P/E Ratio
21.3x15.8x−0.5x
PEG Ratio
0.510.030.00
Price/Book
2.0x2.0x2.6x
Price / LTM Sales
2.9x2.1x3.3x
Upside (Analyst Target)
16.4%36.3%45.1%
Fair Value Upside
Unlock18.7%7.4%Unlock

Analyst Ratings

10 Buy
7 Hold
1 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 415.88
(+16.89% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.17%
Dividend Yield
1.86%
Industry Median 3.35%
Annualised payout
6.80
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
0.09 / 0.0418
Revenue / Forecast
2.63B / 2.68B
EPS Revisions
Last 90 days

HLN Income Statement

People Also Watch

259.00
LGEN
+1.97%
5,572.0
RKT
+0.04%
401.50
WPP
-0.47%
1,852.00
SSE
+0.27%
548.20
MRON
+1.93%

FAQ

What Stock Exchange Does HALEON Trade On?

HALEON is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for HALEON?

The stock symbol for HALEON is "HLN."

What Is the HALEON Market Cap?

As of today, HALEON market cap is 32.84B.

What Is HALEON's Earnings Per Share (TTM)?

The HALEON EPS (TTM) is 0.17.

When Is the Next HALEON Earnings Date?

HALEON will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is HLN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has HALEON Stock Split?

HALEON has split 0 times.

How Many Employees Does HALEON Have?

HALEON has 24561 employees.

What is the current trading status of HALEON (HLN)?

As of 04 Aug 2025, HALEON (HLN) is trading at a price of 355.80, with a previous close of 365.40. The stock has fluctuated within a day range of 355.80 to 365.40, while its 52-week range spans from 346.10 to 419.40.

What Is HALEON (HLN) Price Target According to Analysts?

The average 12-month price target for HALEON is GBP415.882, with a high estimate of GBP503 and a low estimate of GBP315. 10 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +16.89% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.